BPO Share Price

Open N/A Change Price %
High N/A 1 Day N/A N/A
Low N/A 1 Week N/A N/A
Close N/A 1 Month N/A N/A
Volume N/A 1 Year N/A N/A
52 Week High N/A
52 Week Low N/A
BPO Important Levels
Resistance 2 N/A
Resistance 1 N/A
Pivot N/A
Support 1 N/A
Support 2 N/A
ASX Australia Most Active Stocks
AGO 0.03 0.00%
AGO 0.03 0.00%
AGO 0.03 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
FAR 0.08 0.00%
FAR 0.08 0.00%
FAR 0.08 0.00%
DJS 3.99 0.00%
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
BNV 0.03 50.00%
PMQ 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
RAW 0.05 25.00%
RAW 0.05 25.00%
WRR 0.15 25.00%
BYR 0.05 25.00%
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
NMI 0.01 -50.00%
NMI 0.01 -50.00%
NMI 0.01 -50.00%
GDY 0.01 -50.00%
AHN 0.03 -25.00%

BioProspect Ltd (ASX: BPO)

BPO Technical Analysis 1
As on N/A BPO Share Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS.
BPO Target for March
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
BPO Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.bioprospect.com
BPO Address
145 Stirling Highway
Suite 25
Nedlands, WA 6009
Phone: 61 8 9389 3170
Fax: 61 8 9389 3199
BPO Latest News
BRIEF-Medibio appoints US-based Jack Cosentino as CEO   Reuters   - 16th Feb 17
Medibio shares rise on achieving high accuracy in diagnosing depression   Proactive Investors Australia   - 22nd Dec 16
BRIEF-Medibio enters into binding agreement with Medtronic   Reuters   - 24th Nov 16
Medibio Ltd to outline major raising   Proactive Investors Australia   - 16th Nov 16
The CEO Sessions   Finance News Network   - 01st Nov 16
Medibio partners with HBF for 'Mental Health Check-in'   Finance News Network   - 11th Oct 16
MediBio a 'speculative buy'   The Australian Financial Review   - 03rd Dec 15
Medibio's CEO Kris Knauer brings near-term revenues to Proactive's Luncheons   Proactive Investors Australia   - 19th Aug 15
What's Happening to the Share Price of Medibio Ltd?   Daily Reckoning - Australian Edition   - 10th Aug 15
BioProspect shares in halt for decision on Invatec and Heartlink acquisition   Proactive Investors Australia   - 18th Mar 14
Interactive Technical Analysis Chart BioProspect Ltd ( BPO ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on BioProspect Ltd
BPO Business Profile
BioProspect Limited is engaged in the research, development, and commercialization of natural products and technology in the human health and personal care, animal health and nutrition, and agricultural sectors in Australia and internationally. The company offers agriculture/animal health products comprising Qcide, a natural insecticide for controlling hygiene insects, including flies, mosquitoes, and ants; AGRIPRO topical gel for the treatment of surface wounds and abrasions, and skin conditions; and GI-GUARD oral paste for horses. It also provides human health/skin care products, such as DEMURE natural skin care products, and L'AZURE cosmetics; and therapeutic products, including pain relief sprays and gels, and emu oil capsules under the REGEN brand. In addition, the company is involved in the oil and gas exploration and development activities primarily in the Philippines. BioProspect Limited was founded in 1998 and is based in Nedlands, Australia.